VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

This study has been completed.

Study NCT00063713 Information provided by Millennium Pharmaceuticals, Inc.

First Received: July 2, 2003 Last Updated: February 7, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	December 2005 (Final data collection date for primary outcome measure)